Amgen
AMGN
1,884 hedge funds and large institutions have $89.5B invested in Amgen in 2019 Q3 according to their latest regulatory filings, with 118 funds opening new positions, 721 increasing their positions, 783 reducing their positions, and 86 closing their positions.
37% more first-time investments, than exits
New positions opened: 118 | Existing positions closed: 86
15% more funds holding in top 10
Funds holding in top 10: 54 → 62 (+8)
1% more funds holding
Funds holding: 1,865 → 1,884 (+19)
4% more capital invested
Capital invested by funds: $86B → $89.5B (+$3.54B)
0.6% more ownership
Funds ownership: 76.58% → 77.17% (+0.6%)
8% less repeat investments, than reductions
Existing positions increased: 721 | Existing positions reduced: 783
22% less call options, than puts
Call options by funds: $1.01B | Put options by funds: $1.29B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$775M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$554M |
| 3 |
N
Natixis
Paris,
France
|
+$228M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$218M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$156M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$762M |
| 2 |
BlackRock
New York
|
-$327M |
| 3 |
Two Sigma Advisers
New York
|
-$317M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$302M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$249M |
AMGN Hedge Fund Activity: Q3 2019 in Review
1,884 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2019, worth a combined $89.5B — up 4.1% from $86B a quarter earlier.
Buyers outnumbered sellers: 118 funds opened new AMGN positions and 86 closed out — a net gain of 32 holders — while 721 added to existing stakes and 783 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $775M. The largest seller was Capital International Investors, cutting an estimated $762M.
- 1,884 institutional investors held Amgen (AMGN) as of Q3 2019, up from 1,865 in Q2 2019.
- Funds reported $89.5B of Amgen stock for Q3 2019, up 4.1% quarter-over-quarter.
- 118 funds opened new Amgen positions in Q3 2019 and 86 closed out, a net change of +32 holders.
- The largest Amgen buyer in Q3 2019 was Capital Research Global Investors, an estimated $775M added.
- The largest Amgen seller in Q3 2019 was Capital International Investors, an estimated $762M sold.
Based on aggregated 13F filings for Q3 2019.